Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer.
Hotta K, Suzuki E, Di Maio M, Chiodini P, Fujiwara Y, Takigawa N, Ichihara E, Reck M, Manegold C, Pilz L, Hisamoto-Sato A, Tabata M, Tanimoto M, Shepherd FA, Kiura K.
Hotta K, et al. Among authors: manegold c.
Lung Cancer. 2013 Jan;79(1):20-6. doi: 10.1016/j.lungcan.2012.10.007. Epub 2012 Nov 17.
Lung Cancer. 2013.
PMID: 23164554
Review.